See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2018_Vyant_Bio_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.3832674319357592, 'aggregate_val': 35406000, 'exp_sum': 57409000, 'exp_to_value': {'IntangibleAssets': 17257000, 'AssetsNonCurrent': 22003000, 'AssetsCurrent': 9347000, 'PropertyPlantAndEquipment': 4056000, 'remainder_Assets': 4746000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.31003091721058057, 'aggregate_val': 52221000, 'exp_sum': 75686000, 'exp_to_value': {'IntangibleAssets': 17992000, 'AssetsNonCurrent': 23465000, 'AssetsCurrent': 23206000, 'PropertyPlantAndEquipment': 5550000, 'remainder_Assets': 5473000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001349929')"} |
Graph
Absolute values for 0001349929, Vyant Bio Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 17,992,000 |
| 1 | AssetsNonCurrent | 23,465,000 |
| 2 | AssetsCurrent | 23,206,000 |
| 3 | PropertyPlantAndEquipment | 5,550,000 |
| 4 | remainder_Assets | -17,992,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 19,640,000 |
| 7 | remainder_Liabilities | 5,816,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 18,070,000 |
| 10 | GeneralAndAdministrativeExpense | 19,894,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 4,990,000 |
| 15 | ResearchAndDevelopmentExpense | 4,789,000 |
| 16 | remainder_Expenses | -2,079,000 |
| 17 | remainder_Revenues | 29,121,000 |
| 18 | remainder_NetIncome | -4,337,000 |
| 19 | remainder_ComprehensiveNetIncome | 69,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 52,221,000 |
| 1 | Liabilities | 25,456,000 |
| 2 | Expenses | 45,664,000 |
| 3 | Revenues | 29,121,000 |
| 4 | StockholdersEquity | 26,765,000 |
| 5 | NetIncome | -20,880,000 |
| 6 | ComprehensiveNetIncome | -20,811,000 |
| 7 | BaseVar | 78,434,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.463 |
| 9 | EconomicCapitalRatio | 1.30 |
Edgar->Model Mapping
Feature Distribution
Change over Time
